Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | %Female (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Behavioural Pharmacology | journal | 1.197 Q1 | 87 | 75 | 214 | 3638 | 568 | 205 | 2.47 | 48.51 | 44.13 | |
52 | Pharmaceutical Research | journal | 1.197 Q1 | 229 | 280 | 808 | 11542 | 3096 | 803 | 3.59 | 41.22 | 29.86 | |
53 | Clinical Therapeutics | journal | 1.185 Q1 | 150 | 195 | 616 | 7159 | 2396 | 547 | 3.65 | 36.71 | 30.04 | |
54 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | 32.88 | |
55 | Journal of Natural Products | journal | 1.162 Q1 | 161 | 395 | 1195 | 9805 | 3306 | 1190 | 2.72 | 24.82 | 35.22 | |
56 | Receptors and Channels | journal | 1.143 Q1 | 44 | 0 | 59 | 0 | 169 | 56 | 2.53 | 0.00 | 0.00 | |
57 | Journal of Biomolecular Screening | journal | 1.140 Q1 | 86 | 103 | 218 | 2841 | 843 | 215 | 3.67 | 27.58 | 34.55 | |
58 | Antiviral Research | journal | 1.139 Q1 | 151 | 118 | 262 | 5565 | 980 | 260 | 3.40 | 47.16 | 37.55 | |
59 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | 23.96 | |
60 | Journal of Clinical Pharmacology | journal | 1.119 Q1 | 130 | 153 | 435 | 4640 | 1727 | 431 | 3.79 | 30.33 | 33.73 | |
61 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | 29.14 | |
62 | Investigational New Drugs | journal | 1.068 Q1 | 97 | 64 | 165 | 2161 | 577 | 162 | 3.27 | 33.77 | 31.39 | |
63 | European Journal of Pharmacology | journal | 1.060 Q1 | 203 | 754 | 2151 | 30523 | 6429 | 2141 | 2.86 | 40.48 | 34.55 | |
64 | Experimental and Clinical Psychopharmacology | journal | 1.030 Q1 | 101 | 49 | 109 | 2401 | 263 | 108 | 1.83 | 49.00 | 43.79 | |
65 | Pharmacological Research | journal | 0.992 Q1 | 169 | 137 | 455 | 5965 | 1448 | 450 | 3.25 | 43.54 | 37.52 | |
66 | American Journal of PharmacoGenomics | journal | 0.965 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
67 | Pharmacogenomics | journal | 0.939 Q2 | 100 | 115 | 282 | 4762 | 853 | 244 | 3.40 | 41.41 | 36.81 | |
68 | Pharmacology Biochemistry and Behavior | journal | 0.929 Q2 | 148 | 257 | 816 | 13069 | 2042 | 813 | 2.40 | 50.85 | 40.60 | |
69 | Journal of Ethnopharmacology | journal | 0.924 Q2 | 231 | 407 | 1042 | 12847 | 2637 | 1033 | 2.27 | 31.57 | 40.62 | |
70 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | 30.52 | |
71 | Chirality | journal | 0.908 Q2 | 83 | 110 | 346 | 3419 | 837 | 340 | 2.36 | 31.08 | 31.67 | |
72 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | 24.39 | |
73 | PharmacoEconomics | journal | 0.898 Q2 | 118 | 137 | 334 | 5024 | 938 | 307 | 2.56 | 36.67 | 30.43 | |
74 | Planta Medica | journal | 0.896 Q2 | 135 | 260 | 769 | 5554 | 1740 | 761 | 2.04 | 21.36 | 38.53 | |
75 | Therapeutic Drug Monitoring | journal | 0.889 Q2 | 102 | 150 | 365 | 3925 | 1105 | 348 | 3.07 | 26.17 | 36.99 | |
76 | British Journal of Clinical Pharmacology | journal | 0.879 Q2 | 167 | 207 | 632 | 5596 | 1889 | 534 | 2.93 | 27.03 | 32.96 | |
77 | Journal of Pharmacological Sciences | journal | 0.867 Q2 | 101 | 172 | 598 | 6880 | 1421 | 586 | 2.46 | 40.00 | 22.96 | |
78 | Cancer Chemotherapy and Pharmacology | journal | 0.858 Q2 | 122 | 222 | 488 | 6029 | 1385 | 488 | 2.89 | 27.16 | 26.40 | |
79 | Progress in Medicinal Chemistry | journal | 0.849 Q2 | 38 | 8 | 23 | 1253 | 67 | 20 | 2.60 | 156.63 | 27.27 | |
80 | Steroids | journal | 0.848 Q2 | 114 | 141 | 356 | 4434 | 1156 | 356 | 3.12 | 31.45 | 40.31 | |
81 | Prostaglandins and Other Lipid Mediators | journal | 0.840 Q2 | 86 | 54 | 146 | 2468 | 317 | 143 | 2.14 | 45.70 | 42.62 | |
82 | Anti-Cancer Drugs | journal | 0.811 Q2 | 102 | 153 | 409 | 5742 | 1082 | 406 | 2.81 | 37.53 | 32.18 | |
83 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | 35.50 | |
84 | Clinical Neuropharmacology | journal | 0.801 Q2 | 85 | 62 | 201 | 1823 | 590 | 184 | 3.10 | 29.40 | 26.78 | |
85 | Bulletin of Mathematical Biology | journal | 0.790 Q2 | 97 | 105 | 194 | 4028 | 399 | 193 | 2.00 | 38.36 | 27.75 | |
86 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | 31.43 | |
87 | Journal of Peptide Science | journal | 0.775 Q2 | 73 | 110 | 248 | 3484 | 494 | 239 | 1.84 | 31.67 | 34.81 | |
88 | International Immunopharmacology | journal | 0.768 Q2 | 149 | 243 | 551 | 8584 | 1363 | 547 | 2.41 | 35.33 | 39.56 | |
89 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.767 Q2 | 99 | 94 | 386 | 4860 | 1009 | 382 | 3.03 | 51.70 | 34.37 | |
90 | Phytomedicine | journal | 0.758 Q2 | 141 | 129 | 326 | 3506 | 758 | 317 | 2.02 | 27.18 | 29.10 | |
91 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.757 Q2 | 68 | 68 | 264 | 2230 | 494 | 256 | 1.95 | 32.79 | 30.43 | |
92 | Cardiovascular Drugs and Therapy | journal | 0.756 Q2 | 79 | 56 | 186 | 2148 | 330 | 159 | 1.47 | 38.36 | 20.16 | |
93 | BMC Pharmacology | journal | 0.755 Q2 | 48 | 14 | 65 | 494 | 161 | 65 | 2.37 | 35.29 | 21.57 | |
94 | Addiction Biology | journal | 0.754 Q2 | 93 | 33 | 132 | 2367 | 259 | 120 | 2.05 | 71.73 | 24.43 | |
95 | Drug News and Perspectives | journal | 0.747 Q2 | 53 | 80 | 249 | 3363 | 479 | 248 | 1.72 | 42.04 | 31.71 | |
96 | European Journal of Medicinal Chemistry | journal | 0.744 Q2 | 203 | 176 | 391 | 5052 | 1088 | 391 | 2.54 | 28.70 | 37.41 | |
97 | Fundamental and Clinical Pharmacology | journal | 0.733 Q2 | 85 | 61 | 233 | 2803 | 624 | 231 | 2.37 | 45.95 | 35.12 | |
98 | Journal of Cardiovascular Pharmacology | journal | 0.730 Q2 | 109 | 199 | 823 | 7462 | 1602 | 821 | 1.87 | 37.50 | 30.55 | |
99 | Journal of Experimental Therapeutics and Oncology | journal | 0.713 Q2 | 40 | 23 | 83 | 967 | 183 | 83 | 1.87 | 42.04 | 38.58 | |
100 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 | 29.63 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®